Vascular disease
Showing 26 - 50 of >10,000
Atherosclerotic Vascular Disease, Type2 Diabetes, Microvascular Dysfunction Trial in New York, Toronto (Placebo, Evolocumab)
Completed
- Atherosclerotic Vascular Disease
- +2 more
- Placebo
- Evolocumab
-
New York, New York
- +1 more
Jul 11, 2022
Rumination, Depressive Symptoms, Blood Pressure Trial (Rumination-Focused Cognitive Behavior Therapy)
Not yet recruiting
- Rumination
- +2 more
- Rumination-Focused Cognitive Behavior Therapy
- (no location specified)
Aug 4, 2023
NPDR - Non Proliferative Diabetic Retinopathy Trial in Coimbra (Laboratory tests)
Completed
- NPDR - Non Proliferative Diabetic Retinopathy
- Laboratory tests
-
Coimbra, PortugalAIBILI- Association for Biomedical Research and Inovation on Lig
Oct 11, 2022
Peripheral Arterial Disease, Vascular Diseases, Stenosis Trial in Auckland (Efemoral Vascular Scaffold System (EVSS))
Recruiting
- Peripheral Arterial Disease
- +3 more
- Efemoral Vascular Scaffold System (EVSS)
-
Auckland, New ZealandAuckland City Hospital
Mar 31, 2022
Study of the Diabetic Foot and Evolution.
Not yet recruiting
- Diabetes Mellitus
- +5 more
- BIOIMPEDANCEMETRY
- (no location specified)
Mar 24, 2023
Pulmonary Vascular Disease, Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zurich
Active, not recruiting
- Pulmonary Vascular Disease
- +2 more
- Relocation from HA to LA
-
Zurich, SwitzerlandRespiratory Clinic, University Hospital of Zurich
Oct 17, 2023
Pulmonary Vascular Disease, Pulmonary Artery Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zurich
Recruiting
- Pulmonary Vascular Disease
- +2 more
- Relocation to sea level
-
Zurich, SwitzerlandUniversity Hospital Zurich
Aug 9, 2023
Type 2 Diabetes Trial (Ertugliflozin, Placebo, Glycemic Rescue)
Pulmonary Vascular Disease, Pulmonary Artery Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zurich
Active, not recruiting
- Pulmonary Vascular Disease
- +2 more
- Assessment without intervention at High altitude
- Relocation to sea level for 2 days
-
Zurich, SwitzerlandUniversity Hospital Zurich
Oct 2, 2023
Peripheral Vascular Diseases, Percutaneous Intervention Via Femoral Artery Trial in Beijing (Perclose ProGlide, Angio-seal VIP)
Recruiting
- Peripheral Vascular Diseases
- Percutaneous Intervention Via Femoral Artery
- Perclose ProGlide
- Angio-seal VIP
-
Beijing, Beijing, ChinaFuwai Hospital, National Center for Cardiovascular Disease, Chin
Apr 18, 2022
Peripheral Artery Disease, Peripheral Vascular Disease Trial in Palo Alto (High PAD risk Alert)
Not yet recruiting
- Peripheral Artery Disease
- Peripheral Vascular Disease
- High PAD risk Alert
-
Palo Alto, CaliforniaStanford University
Jul 11, 2022
Post-operative Cerebral Small Vascular Disease(CSVD)
Recruiting
- Cerebral Small Vessel Diseases
- Long Term Adverse Effects
-
Shanghai, Shanghai, ChinaRenji Hospital, Shanghai Jiao Tong University, School of Medicin
Apr 28, 2022
Lifestyle Practices With Chronic Diseases Among Different
Recruiting
- Chronic Diseases in Adolescence
- +2 more
- Quantitative sampling
- Qualitative interviews
-
Islamabad, PakistanHealth Services Academy
May 9, 2023
Asan Aorta and Peripheral Registry
Not yet recruiting
- Aorta Disease
- Peripheral Artery Disease
- Treatment
-
Seoul, Korea, Republic ofAsan Medical Center
Aug 31, 2023
Pulmonary Vascular Disease Trial in Durham (GE-141, Hyperpolarized 129Xenon gas, MRI)
Completed
- Pulmonary Vascular Disease
- GE-141, Hyperpolarized 129Xenon gas
- MRI
-
Durham, North CarolinaDuke University Medical Center
Jan 28, 2022
Studies of Neuregulin/ERBB Signaling in Human Heart
Recruiting
- Heart Disease
- +2 more
-
Portland, MaineMaine Medical Center
Nov 22, 2022
Pulmonary Vascular Disease, Pulmonary Artery Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zürich
Recruiting
- Pulmonary Vascular Disease
- +2 more
- 6-minute walk distance (6MWD) test
- 6-minute walk distance (6MWD) test with supplemental oxygen (3 l/min, nasal)
-
Zürich, SwitzerlandUniversity Hospital Zürich
Aug 18, 2023
Hand Acceleration Time Assessment With Ultrasound Doppler
Recruiting
- Upper Limb Ischemia
- Vascular Disease
- Hand Doppler Ultrasound
-
L'Hospitalet De Llobregat, Barcelona, SpainHospital Universitari de Bellvitge
Aug 6, 2023
Metabolomic Analysis of Systemic Sclerosis
Recruiting
- Scleroderma (Limited and Diffuse)
- +4 more
- - Skin biopsy - Urine sample - Blood sample
-
Dijon, France
- +3 more
Jul 7, 2022
Atherosclerosis Trial in Portland (R-alpha lipoic acid)
Active, not recruiting
- Atherosclerosis
- R-alpha lipoic acid
-
Portland, OregonOregon Health & Science University
Apr 19, 2022
Diabete Type 2, Diabetic Foot, Neuropathy, Diabetic Trial (LSCI)
Not yet recruiting
- Diabete Type 2
- +4 more
- LSCI
- (no location specified)
May 2, 2023
PIMR and Pulmonary Vascular Disease
Recruiting
- Pulmonary Hypertension
- Pulmonary Index of Microcirculatory Resistance
- +2 more
-
Los Angeles, CaliforniaRonald Reagan UCLA Medical Center
Apr 24, 2023
Stroke and Carotid-Cerebral Vascular Disease After CABG -Pilot
Enrolling by invitation
- Coronary Artery Bypass
-
Shanghai, Shanghai, ChinaRuijin Hospital Shanghai Jiao Tong University School of Medicine
Mar 13, 2022
Renal Autotransplantation; Case Series
Enrolling by invitation
- Renal Vascular Disease
- +5 more
- Pre-Operative Information
- +3 more
-
Dallas, TexasLiver Institute of Methodist Dallas Medical Center
Dec 20, 2022
Coronary Artery Disease, Peripheral Vascular Disease, Myocardial Infarction Trial in Falls Church (Vorapaxar, Vorapaxar and
Completed
- Coronary Artery Disease
- +2 more
- Vorapaxar
- +3 more
-
Falls Church, VirginiaInova Fairfax Hospital
Jul 22, 2022